The European market for vascular access devices will see slight growth over the forecast period, driven in large part by the rising adoption of PICCs in all European countries, as well as the rising adoption of new technologies such as power-injectable devices, and devices with antimicrobial coatings. However, market revenues will be hindered to some extent by declining ASPs resulting from pricing pressures and increasing competition. Importantly, the impact of the COVID-19 pandemic on procedures, unit sales, and revenues has been incorporated into the market projections.
This Medtech 360 Report provides high-level market metrics for the vascular access device market in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
- Vascular Access Devices - Market Insights - Europe (Supplemental)
Author(s): Jackie Liu
Jackie Liu is an analyst within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in peripheral vascular device markets. Jackie holds a PhD in Molecular Genetics and a MPH in Epidemiology from the University of Toronto. Prior to her current position, Jackie worked at multiple public health organizations in Ontario, gaining extensive experience with reporting and analyzing large-scale health data.